Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hahn

Showing results (781-790 of 866) with videos related to

Pageof 87
Sort By:
Scientific Reports|May 7, 2024
Genetic polymorphisms associated with adverse pregnancy outcomes in nulliparasRaiyan R Khan, Rafael F Guerrero, Ronald J Wapner, et al.
The Oncologist|January 14, 2023
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell CarcinomasOmar Alhalabi, Jonathan Thouvenin, Sylvie Négrier, et al.
Behavioural Brain Research|November 20, 2019
Effects of opioid receptor ligands in rats trained to discriminate 22 from 2 hours of food deprivation suggest a lack of opioid involvement in eating for hungerDavid C Jewett, Anica Klockars, Travis R Smith, et al.
G3 (Bethesda, Md.)|May 28, 2013
The evolution of the Anopheles 16 genomes projectDaniel E Neafsey, George K Christophides, Frank H Collins, et al.
JAMA Network Open|August 30, 2022
Association of Genetic Predisposition and Physical Activity With Risk of Gestational Diabetes in Nulliparous WomenKymberleigh A Pagel, Hoyin Chu, Rashika Ramola, et al.
The Journal of Clinical Investigation|February 23, 2016
Gonadal steroid-dependent effects on bone turnover and bone mineral density in menJoel S Finkelstein, Hang Lee, Benjamin Z Leder, et al.
Molecular Biology and Evolution|May 5, 2026
IQ-TREE 3: Phylogenomic Inference Software using Complex Evolutionary ModelsThomas K F Wong, Nhan Ly-Trong, Huaiyan Ren, et al.
The Oncologist|November 30, 2023
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint TherapyAndrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, et al.
Frontiers in Physiology|October 30, 2024
Cancer and lymphatic marker FOXC2 drives wound healing and fibrotic tissue formationMaia B Granoski, Katharina S Fischer, William W Hahn, et al.
Translational Behavioral Medicine|June 8, 2026
Implementing intervention mapping to tailor the evidence-based PREDIMED intervention for medically underserved prostate cancer patientsRebekka S Garcia, Carrie R Daniel, Cindy Hwang, et al.
Pageof 87

Showing results (781-790 of 866) with videos related to

Sort By:
Pageof 87
Scientific Reports|May 7, 2024
Genetic polymorphisms associated with adverse pregnancy outcomes in nulliparasRaiyan R Khan, Rafael F Guerrero, Ronald J Wapner, et al.
The Oncologist|January 14, 2023
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell CarcinomasOmar Alhalabi, Jonathan Thouvenin, Sylvie Négrier, et al.
Behavioural Brain Research|November 20, 2019
Effects of opioid receptor ligands in rats trained to discriminate 22 from 2 hours of food deprivation suggest a lack of opioid involvement in eating for hungerDavid C Jewett, Anica Klockars, Travis R Smith, et al.
G3 (Bethesda, Md.)|May 28, 2013
The evolution of the Anopheles 16 genomes projectDaniel E Neafsey, George K Christophides, Frank H Collins, et al.
JAMA Network Open|August 30, 2022
Association of Genetic Predisposition and Physical Activity With Risk of Gestational Diabetes in Nulliparous WomenKymberleigh A Pagel, Hoyin Chu, Rashika Ramola, et al.
The Journal of Clinical Investigation|February 23, 2016
Gonadal steroid-dependent effects on bone turnover and bone mineral density in menJoel S Finkelstein, Hang Lee, Benjamin Z Leder, et al.
Molecular Biology and Evolution|May 5, 2026
IQ-TREE 3: Phylogenomic Inference Software using Complex Evolutionary ModelsThomas K F Wong, Nhan Ly-Trong, Huaiyan Ren, et al.
The Oncologist|November 30, 2023
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint TherapyAndrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, et al.
Frontiers in Physiology|October 30, 2024
Cancer and lymphatic marker FOXC2 drives wound healing and fibrotic tissue formationMaia B Granoski, Katharina S Fischer, William W Hahn, et al.
Translational Behavioral Medicine|June 8, 2026
Implementing intervention mapping to tailor the evidence-based PREDIMED intervention for medically underserved prostate cancer patientsRebekka S Garcia, Carrie R Daniel, Cindy Hwang, et al.
Pageof 87